iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine
Anas Younes et al.
iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine
Catherine Bollard et al.
CAR T-cells in lymphoma: where are we now?
David Maloney et al.
Novel targets and agents for lymphoma
John Kuruvilla et al.
Pre-clinical activity of tipifarnib in CTCL